Health Archive » May, 2007

Health - May, 2007

136 articles

• Court Tosses Verdict, $3M Award Against Wyeth
• DenTek Answers Medtech's Infringement Claims
• Townsend Steps Up Its Biotech Team
• Judge Frowns At McDermott Head's "Happy" Remark
• Consumer Group Backs Purchasers In Fraud Case
• California Drops Claims Against Bristol-Myers
• Becton Dickinson Seeks More Time In Antitrust Suit
• Bristol-Myers Pleads Guilty, Pays $1M In Fines
• Judge Gives Go-Ahead To Prilosec Patent Suit
• Amended Complaint Filed Over Ditropan
• National Century Ruling Stalls Discovery
• Cordis Gets New Stent Patent, Sues Abbott
• Pfizer To Appeal Lipitor Patents In Norway
• Purdue, Impax Patent Fight Comes To An End
• Medicare Fraud Charges Brought In Florida
• Roche Loses First Accutane Trial, Jury Awards $2.5M
• Takeda Files New Suit Against Teva Over Prevacid
• House Threatens FDA With Subpoena
• Whistleblower Suit Against Schering To Proceed
• Court Tosses ERISA Suit Against Blue Cross
• FDA Takes Aim At Unapproved Cough Drugs
• Judge Dismisses ERISA Suit Against Aetna
• Court Affirms Rejection Of "Aspirina" Mark
• Judge Sets Evidentiary Hearing In Seroquel Case
• Judge Throws Out Slew Of Cases Against Pfizer
• Legislation To Fund State Health Courts Introduced
• Two Suits Added To OxyContin Antitrust Case
• Court Blocks Dismissal Of Deloitte Suit
• DOJ Settles With Arizona Health Group
• Supreme Court Shouldn't Hear Tamoxifen Cases: SG
• Federal and State Suits Collide in Blue Cross Case
• Life Sciences Industry Says FDA Needs Reform
• Ivax Pushes For Depomed To Share Memos
• Altana, Sun Squabble Over Discovery Motions
• Ortho Evra Cases Consolidated In Ohio
• Report On Medicaid Financing Fuels Debate
• Fresenius Renews Bid To Stay Damages Trial
• Appeals Court Rules Patent Attorney Deceived PTO
• Counterclaims Filed In HIV Treatment Patent Suit
• Kansas Disability Center Sues Former Employees
• Norvasc Patent Still Invalid: Court
• Immucor Settles for $2.5 Million
• FDA Issues Warning Over Avandia Amid Outcry
• Biotech Bankruptcies Face IP Challenges
• Court Lifts Order Barring Teva's Generic Lotrel
• Home Health Care Workers Fight For Overtime
• Six Men Accused Of Rigging Army Hospital Contracts
• AstraZeneca Sued Over Seroquel Promotions
• Takeda Sues Over Diabetes Drug Patent
• Zydus Takes Aim At Three Rivers' Hep C Patent
• DOJ Wants More Info On UnitedHealth Purchase
• Invitrogen Sues Harvard Over Cloning Patent
• Boston Scientific Tries To Settle Guidant Claims
• SeraCare Emerges, Settles Securities Suit
• California Supreme Court Backs Stem Cell Agency
• Judge Grants Bid To Toss BioSafe's Ch. 11 Case
• Senate Reviews Sales Practices For Private Medicare
• Merck Files Second Suit Against Teva Over Singulair
• Biotech Co. Fires Back Against Applera
• Abbott Wants New J&J Stent Patent Declared Invalid
• Cases Added to Suit Over Wyeth, Pfizer HRT
• Judge Dismisses Bavarian's Trade Secrets Case
• AstraZeneca Sued Over Breast Cancer Drug
• Kinetic, Wake Forest File VAC Patent Complaints
• Sanofi-Aventis Sues To Protect Ambien Market
• Roche Workers Lose Appeal Of ERISA Claims
• House Unveils Bill To Ban Deceptive Health Care Ads
• Abbott Sues To Protect Depakote ER
• FDA Improvement Act Introduced In House
• Patients Win Right To Know What Doctors Can Do
• St. Vincent Trustee Objects To Disclosure Statement
• Allergan, Inamed Smooth Out Concerns Over Reloxin
• SEC Sends Biovail Wells Notice
• Supreme Court Won't Touch EPO Patent Spat
• Par's ANDA Leads To Infringement Suit
• Schering Faces Class Action Over Alleged Kickbacks
• Blue Cross Takes New Stance On Rescission Policies
• Court Keeps Aciphex Free Of Generic Competition
• Wyeth's Sales Tactics Not Anti-Competitive: Court
• Study: VA Exaggerated Success Of Medical System
• Plavix Charges Settled, But More May Be Coming
• J&J Keeps Cheap Risperdal Off Shelves
• Edwards Unit Sues Rival Over Catheter Device
• Genendo Loses Drug Importation Appeal
• Allergan Litigates Over Eye Drop Patent
• Boston Scientific Faces German Patent Suit
• Drug Bill To Change ANDA Petition Process
• Group Says "Enough" In Pfizer Unit Ch. 11 Case
• Purdue, Employees To Pay $700M In OxyContin Case
• Digene Loses Belated Bid For Ban On Rival HPV Tests
• U.S. Regulators Crack Down On Medicare Fraud
• Clinton Unveils Pact To Slash AIDS Drug Prices
• Laser Eye Surgery Rivals Joust Over Patents
• Biovail Chair Fails To Reach Deal With Regulator
• China's Ex-FDA Head To Go On Trial For Corruption
• Cardinal Health Settles Suit For $600M
• Hospital To Pay $7.4M For Doctor's Misdeeds
• District Court Denies Abbott's Motion To Dismiss
• St. Vincent, Caritas Bury Hatchet Over Sale Terms
• Medicis Settles Off-Label Marketing Charges
• House Hears Testimony On RESPECT Act
• Senate Drug Importation Amendment Squashed
• Top Companies Join In Push For Health Care Reform
• Philippines Seeks To Invalidate Pfizer Patent
• Purdue Pharma Settles With States Over OxyContin
• Tenet Escapes Medicare Billing Lawsuit
• Hospital Operator Seeks Transfer Of Antitrust Suit
• Thailand Makes IP Blacklist For Compulsory Licenses
• U.K. Plaintiffs Dismissed From Hemophilia Case
• Study: Bill Could Drive Up Drug Costs by Billions
• Lundbeck Loses U.K. Patent Case Over Cipralex
• CalPERS Seeks Proxy Access At UnitedHealth
• Judge Excludes Accutane Maker's Own Assessments
• Men Sentenced For Medicare Fraud, HIPAA Violations
• Brazil Breaks Patent On Merck's AIDS Drug
• Lawmakers, Unions Fight FDA Plan To Close Labs
• German Court OKs Bayer-Schering Merger
• AstraZeneca Warns Against "Procedural Chaos"
• Attorney-Client Privilege And Health Insurers
• FDA Gives Mylan Tentative OK On Generic Femara
• Court Approves $93M Cigna Settlement
• Reed Smith Nabs Experienced FDA Partner
• BioSafe Brokers $6M Deal With Creditors
• Ex-Chair Of House Ways & Means Joins Buchanan
• Health Plan Contraception Exclusion Not Discriminatory
• Merck Alleges Infringement Of Antibacterial Drug
• Hospital Charged With Anti-Competitive Conduct
• EBG Launches Clinical Trial Help Group
• Biologics Debated At House Subcommittee Hearing
• Bush Opposes Adding Biologic Generics To FDA Bill
• Canadian Court Blocks Generic Celebrex Launch
• Pennsylvania To Review Insurance Merger
• FDA Attempt To Quash Subpoenas Denied
• New Hampshire Data Law Ruled Unconstitutional
• Infertility Claim Against Eli Lilly Dismissed
• Judge Recommends Revoking Impax's Registration